Faculty profile

Brian Shilton

Back to faculty

ProfessorBiochemistryWestern University

Brian Shilton

Professor

Biochemistry

Western University

London, Ontario, Canada

ORCID

Supervision signals

Professors usually supervise graduate students in their department's programs.
No publications on record.
Principal investigator on 7 research grants (7 NSERC), most recently in 2023.
Supervisor on 1 trainee award (1 CIHR), most recently in 2013.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Collaborators

Grants

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile Search on Google Scholar iDORCID

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their Western University profile.

Latest funding

Preparative Ultracentrifuge and Rotors for Western BioCORE Facility
NSERC · 2023 · Principal investigator
$128,886
Development of Optimized Reversible Pin1 Inhibitors to Block Multiple Cancer-Driving Pathways and to Disrupt Immunosuppressive Tumor Microenvironment
CIHR · 2023 · Co-investigator
$100,000
Bio--Layer interferometry system for biomolecular interaction analysis
NSERC · 2021 · Co-investigator
$150,000

All 18 grants and awards

Preparative Ultracentrifuge and Rotors for Western BioCORE Facility

Principal investigatorNSERC2023Research Tools and Instruments

Principal investigators: Shilton, Brian

$128,886

Development of Optimized Reversible Pin1 Inhibitors to Block Multiple Cancer-Driving Pathways and to Disrupt Immunosuppressive Tumor Microenvironment

Co-investigatorCIHR2023Project Grant - PA: Breast Cancer Research

Principal investigators: Lu, Kun Ping; Gillies, Elizabeth R; Magolan, Jakob; Zhou, Xiao Zhen

Keywords: Cancer Immunotherapy; Cancer Signalling; Cancer Therapeutics; Exploratory Translational Cancer Research; Innovative Pharmacological Agents; Molecular Targeted Therapies; Multiple Cancer Pathways; Overcome Cancer Resistance; Pin1 Inhibitors; Triple-Negative Breast Cancer

$100,000

Bio--Layer interferometry system for biomolecular interaction analysis

Co-investigatorNSERC2021Research Tools and Instruments

Principal investigators: Choy, Wing-Yiu

$150,000

High-throughput Crystallization Imaging System

Co-investigatorNSERC2019Research Tools and Instruments

Principal investigators: Shaw, Gary

$149,165

Ion Mobility Mass Spectrometer for Studying Protein Structure and Dynamics

Co-investigatorNSERC2018Research Tools and Instruments

Principal investigators: Konermann, Lars

$149,945

Preprotein Binding by the SecA ATPase

Principal investigatorNSERC2018Discovery Grants Program - Individual

Principal investigators: Shilton, Brian

Keywords: bacterial protein targeting and secretion; chaperone function; DEAD box helicase; membrane transport; oligomerization; preprotein translocase; protein-peptide interactions; protein structure and function; ribosomes and nascent chains; X-ray crystallography and SAXS

$216,000

Robotic Instrumentation to Establish Workflows for Systematic Cell-Based Analyses.

Co-investigatorNSERC2017Research Tools and Instruments

Principal investigators: Litchfield, David

$150,000

Operations and Maintenance Support for a Regional Protein Characterization Facility

Co-investigatorNSERC2017Research Tools and Instruments

Principal investigators: Junop, Murray

$144,600

Delimitation of protein function & interaction networks through peptide arrays

Co-investigatorNSERC2016Research Tools and Instruments

Principal investigators: Li, ShawnShunCheng

$150,000

Role of quinone reductase 2 in stabilizing p53 degradation from the 20S proteasome

SupervisorCIHR2013Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

Principal investigators: Leung, Kevin K

Keywords: 20s Proteosomal Degradation; Antimalarial Drugs; Casein Kinase 2 Inhibitors; Cellular Apoptosis; Flavin Redox Switch; Imatinib; P53 Stabilization; Quinone Reductase 2; Small-Angle X-Ray Scattering; X-Ray Crystallography

$105,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Profile data last refreshed on September 26, 2026 from the university directory, publication records and CIHR, NSERC and SSHRC funding.

Something wrong or missing on this profile? Suggest a correction